Abstract
Although increasing evidences suggest a relationship between hypertension and brain function for years, it is still unclear whether hypertension constitutes a risk factor for cognitive decline and its underlying mechanism. In the present study, an experimental animal model of hypertension simply by feeding rats with high salt diet was employed. We found that long-term high salt intake caused a marked increase of systolic blood pressure linked to a declined regional cerebral blood flow. Fear conditioning and morris water maze behavioral test revealed that high salt diet induced hippocampal dependent spatial reference memory deficits, while a decreased synaptogenesis without neuronal loss in hippocampus was observed in high salt treated rats. Furthermore, we found that high salt induced a decrease of intracellular calcium, which inactivated CaMK II and resulted in dephosphorylation of CREB at Ser133. These findings suggest a novel etiopathogenic mechanism of cognitive deficit induced by hypertension, which is initiated by high salt diet.
Keywords: high salt diet, hypertension, cognitive defects, synaptogenesis, cerebral blood flow
INTRODUCTION
Hypertension, also known as high blood pressure, is a pathological process in which the blood pressure in the arteries is persistently elevated. High blood pressure usually does not cause symptoms. Long-term high blood pressure, however, is a major risk factor for coronary artery disease, stroke, heart failure, peripheral vascular disease, vision loss, and chronic kidney disease [1–4]. Recent researches have implied that hypertension may also play an important role in the development of cognitive impairment, vascular dementia, and Alzheimer's disease (AD)[5–7]. A longitudinal study from 4-year assessment found that the risk of cognitive impairment was increased 2.8 times in persons with hypertension [8]. In persons with hypertension, treatment with antihypertensive drug therapy had a 30% lower incidence of dementia than persons with hypertension not treated with antihypertensive drug therapy [9]. These studies strongly support that there is a tight relationship between blood pressure (BP) and cognitive function, and this connection is biologically complex and still not fully understood.
Neuroimaging has showed that high systolic blood pressure is associated with smaller regional and total brain volumes [10] and reductions in brain volume over time [11]. However, the high diastolic blood pressure does not affect brain volume [12]. Chronic hypertension disrupts cerebral autoregulation [13] and reduces resting cerebral blood flow [14]. Cerebral hypoperfusion may be associated with the dysfunction of synaptic proteins synthesis [15]. Hypertension leading to endothelial dysfunction disrupts the coordinated coupling among neurons, glia, and cerebral blood flow in the microvasculature [16]. It has been reported that high salt intake results in hypertension and causes endothelial dysfunction [17, 18]. We here investigate whether high salt intake induced hypertension leads to cognitive defects and its underlying mechanism. We observed a hippocampal dependent spatial memory deficit linked to loss of synaptic plasticity and a decrease of phosphorylated CREB in rats treated with long-term high salt diet.
RESULTS
Weight and general physical state
During the 9-weeks period of the study, animals were carefully checked and weighed once a week. We did not observe any alterations in general physical state, including grooming, posture, and clasping reflex, due to high salt diet. Statistical analysis did not reveal any significant group effect or group×week interaction in bodyweight (Figure 1B). These data suggested that high salt diet didn't induce significant effect on bodyweight among groups.
Long-term high salt diet significantly raises systolic blood pressure and induces hypertension
High salt is a risk factor for hypertension [20, 21]. To establish the animal model of hypertension, we fed rats with a high salt diet (8% NaCl enriched diet) for 9 weeks. Using tail-cuff plethysmography to measure systolic blood pressure (SBP), rats fed with salt demonstrated a marked increase of SBP by 30±5 mmHg compared to that of control rats after 3 weeks high salt diet (Figure 1C). To test whether chronic hypertension may reduce resting cerebral blood flow in the present study, we employed the Laser Speckle Blood Flow Imager to detect the blood flow of cerebral cortex (Figure 1D). Quantitative analysis showed that high salt diet significantly decreased cerebral blood flow at each time point compared to control group (Figure 1E). Taken together, long-term high salt diet significantly raises systolic blood pressure and induces a chronic and sustained hypertension linked to a decrease of cerebral blood flow.
High salt diet induced hypertension impairs spatial learning and memory in rats
To investigate whether the hypertension leads to cognitive deficit in rats with high salt diet, we tested rats in a classic spatial reference memory task highly involving the hippocampal integrity. Before the water-maze learning and memory test, anxiety and exploratory activity levels were evaluated in the open-field. Hypertension rats with high salt diet displayed similar patterns of anxiety and exploratory activity as control animals (Figure 2A and 2B). Next, we performed fear conditioning experiment to assess the contextual memory. We found that the rats with high saline diet exhibited significant lower freezing behavior compared to control (Figure 2C). Finally, we used MWM test to measure the effects of hypertension induced by high salt intake on hippocampus-dependent spatial learning and memory. No difference in finding the hidden platform was detected between high salt diet and the control groups during 5 days learning trials (Figure 2D). However, the latency to locate the target quadrate in high salt treated rats was significantly increased in the probe trials after removal of the platform compared to control group (Figure 2E), which confirms the impairment of spatial memory retrieval, as a possible result of hypertension. The swimming speed remained comparable among the groups, indicating that high salt diet does not affect motor function (Figure 2F). These data together demonstrate that high salt diet induced hypertension can cause hippocampus-dependent memory deficits.
Loss of dendritic spines in the high salt-treated rats with hypertension
Previous studies have shown that chronic hypertension induces a decrease of cerebral blood flow, which may result in the dysfunction of synaptic proteins synthesis [5, 7]. To study the relationship between cognitive defects and synaptogenesis in the high salt-treated rats with hypertension, we employed Golgi staining and Nissl staining to detect the dendritic spines and the morphological structures of neurons. We found that hypertension rats displayed a marked decrease of dendritic spine density in hippocampus compared to control group (Figure 3A and 3B), while the number of neuron was no significant difference among the groups (Figure 3C and 3D). These data suggested that hypertension related cognitive defect is associated with loss of dendritic spines in hippocampus.
High salt diet downregulates CaMKII/CREB pathway in rats linked to hypertension
Sodium is an essential nutrient and the primary cation in the extracellular fluid [22, 23]. Previous study has shown that rats with high salt diet has higher sodium levels in the interstitial space [21]. To check the effect of high salt intake on intracellular calcium concentration, we used calcium-sensitive indicator Fluo-3 AM to measure intracellular calcium concentration [Ca2+]i by fluorescence. Firstly, the HEK293T cells were exposed to various concentrations (0.9%, 0.92%,0.95%,0.98%) of NaCl for 0.5 h at 37°C. Compared with control group, the morphology of HEK293T cells treated with 0.9-0.95% NaCl have no obvious change. However, 0.98% NaCl induced cell shrinkage, but not filopodia or lamellipodia formation (Figure 4A). Considering the optimal living status of cells for experimentation, we chose 0.9-0.95% NaCl as the final concentration of salt administration in fluorescence assay with calcium dye (Figure 4B). Quantitative analyses showed that [Ca2+]i was decreased in manner of increasing NaCl concentration (Figure 4C).
Some enzymes, including CaMKII, are calcium dependent. We here checked the CaMKII/CREB pathway, which is directed to learning and memory [24]. Western blots showed that high salt diet markedly decreased the expression of phosphorylated- CaMKII at (Thr286) in hippocampus of rats, but did not change the level of total CaMKII (Figure 4D, 4E and 4F). These data suggest that high salt intake leads to inactivation of CaMKII due to the decrease of intracellular calcium in hypertension rats. Accordingly, phosphorylation of CREB, a substrate of CaMKII, is also decreased (Figure 4D, 4G and 4H). Taken together, high salt diet downregulating CaMKII/CREB pathway may be involved in cognitive defects in hypertension rats.
High salt diet doesn't induce Alzheimer like pathological alteration
Hypertension has been reported to be a potential risk factor for Alzheimer's disease (AD)[25, 26]. To investigate whether high salt diet induced hypertension leads to AD like pathological changes, we detected its two hallmark lesions: extracellular senile plaques consisting of β-amyloid and intracellular neurofibrillary tangles made up of the abnormally hyperphosphorylated tau [27, 28]. To test the effect of high salt intake on tau phosphorylation, we here also detected the phosphorylation of tau at Ser199, Ser202/Thr205 (AT8), Thr212, Ser262, Ser396, Ser404 and total tau (Tau5) in rats (Figure 5A). Quantitative analyses showed that tau phosphorylation at above sites had no significant difference among groups (Figure 5B and 5C). We also quantitatively analyzed Aβ levels, and found that Aβ42 were no obvious difference among groups (Figure 5D). Thus, these data strongly support that high salt diet doesn't induce AD like pathological alteration.
DISCUSSION
Here we have shown that 2 months old rats fed 8% NaCl enriched diet for 3 weeks appeared hypertension linked to a decreased regional cerebral blood flow. Moreover, lasting 7 weeks high salt diet induced hypertension leads to a hippocampal dependent memory deficit accompanied with loss of dendritic spines and downregulation of CaMKII/CREB pathway. In the present study, AD like pathological changes were not observed in high salt rats with hypertension. Together our data strongly support the conclusion that hypertension induced by long term high salt diet is a risk factor of cognitive defects.
A survey conducted in China have shown that the average salt intake is inversely proportion to blood pressure [29]. Actually, the average daily sodium intake in China is 10.6 g, 3 times the recommended by the WHO. Therefore, high salt intake might be an important risk factor for hypertension in China [30–32]. Recent study showed that a 12 weeks of chronic 0.9% sodium diet intake after weaning leads to hypertension in adult rats [33]. We here employed a high salt diet (8% NaCl enriched diet) to rats, and found that only 3 weeks of 8% sodium diet intake leads to hypertension in adult rats accompanied with a decrease of cerebral blood flow. Hypertension can induce a change in arteriole endothelial and vascular smooth muscle cells that diminish cerebrovascular reactivity [34], which in turn shifts the cerebral autoregulatory curve and reduces resting cerebral blood flow [14].
Accumulating data implies that hypertension may be involved in development of cognitive impairment [5–7]. However, the underlying mechanism of hypertension related cognitive defects remain still unclear. Some researchers have shown that hypertension associated with smaller regional and total brain volumes, decrease of cerebral blood flow, white matter microstructural damage, vascular oxidative stress and cerebral small vessel disease might be implicated to cognitive impairment [35, 36]. In the present study, we found long term high salt diet induces a hippocampal dependent memory deficit in hypertension rats, which accompany with a decreased synaptogenesis without neuronal loss in hippocampus. It is consistent with previous study showing that oligemia may downregulate the synthesis of proteins necessary for synaptic plasticity and memory formation [15]. Meanwhile, a memory related pathway, CaMKII/CREB signals is downregulated in hypertension rats with high intake. Due to a higher sodium levels in the interstitial space under high salt diet condition [37], we suppose that high sodium stimulates sodium-calcium exchanger to remove calcium from cells [38]. We found that high sodium induces a decrease of intracellular calcium, which in turn inactivates CaMKII and results in dephosphorylation of CREB at Ser133, finally downregulates CaMKII/CREB pathway and leads to cognitive impairment.
Treatment of hypertension may reduce cognitive deficit and Alzheimer's disease (AD)[39, 40]. However, the data from randomized, controlled clinical trials for antihypertensive drug treatment preventing dementia are conflicting [40]. AD is characterized by the presence of two hallmark lesions: extracellular senile plaques consisting of β-amyloid and intracellular neurofibrillary tangles made up of the abnormally hyperphosphorylated tau [41–43]. In the present study, we didn't observe the increase of tau phosphorylation and Aβ in hypertension rats treated with high salt. It might be because the high salt diet is not enough long or salt induced hypertension is not sensitive to AD pathological process.
In summary, our results further confirm that a relative long term high salt intake induces a chronic and sustained hypertension linked to a decrease of cerebral blood flow. Together with loss of dendritic spines and CaMKII/CREB pathway dysfunction results in cognitive defects in hypertension rats. We here report a novel etiopathogenic mechanism of cognitive impairment related to hypertension, which is initiated by high salt diet.
MATERIALS AND METHODS
Chemicals and antibodies
Bicinchoninic acid (BCA) protein detection kit was from Pierce (Rockford, IL, USA). Reagents for cell culture were from Gibco BRL (Gaithersburg, MD, USA). Antibodies employed in this study are listed in Table 1.
Table 1. Antibodies employed in this study.
Antibody | Specific | Type | Dilution | Source |
---|---|---|---|---|
p-CaMK II | Phosphorylated at T286 | Poly- | 1:500 for WB | Cell Signaling Danvers, MA, USA |
CaMK II | Total CaMK II | Mono- | 1:1000 for WB | Cell Signaling Danvers, MA, USA |
P-CREB | Phosphorylated at S133 | Poly- | 1:500 for WB | Cell Signaling Danvers, MA, USA |
CREB | Total CREB | Mono- | 1:1000 for WB | Cell Signaling Danvers, MA, USA |
Tau5 | Total tau | Mono- | 1:1000 for WB | MerckMillipore, Germany |
AT8 | Phosphorylated at Ser202 and Thr205 | Mono- | 1:1000 for WB | Thermo Fisher Scientific, USA |
pS199 | Phosphorylated at S199 | Poly- | 1:500 for WB | Thermo Fisher Scientific, USA |
pT212 | Phosphorylated at Thr212 | Poly- | 1:500 for WB | United Chemi-con, USA |
pS262 | Phosphorylated at S262 | Poly- | 1:500 for WB | Singnalway Antibody, USA |
pS396 | Phosphorylated at S396 | Poly- | 1:1000 for WB | Singnalway Antibody, USA |
pS404 | Phosphorylated at S404 | Poly- | 1:500 for WB | Singnalway Antibody, USA |
DMIA | Total DM1A | Mono- | 1:1000 for WB | Cell Signaling Danvers, MA, USA |
Mono-, monoclonal; poly-, polyclonal; WB, Western blotting.
Animals
The male Sprague-Dawley rats (2 months old, 250± 20 g) were supplied by the Experimental Animal Central of Tongji Medical College, Huazhong University of Science and Technology. After one week of acclimatization, rats were randomly divided in two groups: (i) 12 rats were fed with a standard low-salt diet (0.26% NaCl enriched diet) as a control and (ii) 12 rats were fed with a high-salt diet (8% NaClenriched diet) for 9 weeks [19]. The rats were housed with free access to food and water under a 12:12-hour reversed light-dark cycle, with light on at 8:00 PM. All animal experiments were performed according to the “Policies on the Use of Animals and Humans in Neuroscience Research” revised and approved by the Society for Neuroscience in 1995, and the animal study was approved by the Academic Review Board of Tongji Medical College. After 7 weeks of high salt diet, animals were first submitted to cognitive tests, and then cerebral blood flow, morris water maze, nissl staining, golgi staining, western blotting, immunohistochemistry tests were carried out (Figure 1A).
Blood pressure measurement
Noninvasive BP was measured using a tail-cuff system. Briefly, all rats were held in a restrainer on a warmer for 10 min, a cuff was attached to the tail and BP was then recorded. The systolic blood pressure (SBP) was obtained as an average of three measurements. Each rat was trained to become familiar with this procedure for 3 days and also received the BP measurement as the self-control. The SBP was measured after high saline diet from the second week to the ninth week.
Cerebral blood flow measurement
The rats were anesthetized with 10% chloral hydrate by intraperitoneal injection of 0.5 ml/100g. After anesthesia, the rats were fixed in rat stereotaxic device, and the anterior fontanel and lateral oculi were fully exposed with separation of subcutaneous connective tissue. And then, dental drill (0.5mm) was employed to open the cranial window and remove the parietal bone. Next, the rats were placed into the laser patch-like imaging system (Britton Chance center for biomedical photonics, Wuhan) while the brain tissue in physiological status and the smooth surface of the image were kept. Using 650nm red laser irradiation, the regional cerebral blood flow is recorded under exposure time of 40 milliseconds, frame interval of 1000 milliseconds, recording 60 minutes.
Open-field activity
Anxiety and exploratory activity were evaluated by allowing rats to freely explore an open field for 20 min. The testing apparatus was a classic open field (i.e., a PVC square arena of 100×100 cm2, with 70-cm-high walls). The open field was placed in a part of the room separated from the experimenter and the control station with a black opaque curtain. Rats were individually submitted to a single 20-min session. Because for rodents the middle of a non-familiar arena is anxiogenic, anxiety was studied by analyzing the percentage of time spent in the middle of the arena. To assess exploratory activity, the total distance that the animals covered in the arena was tracked and measured. Data collection was performed using tracking files of the experiment recorded with LabState ver 1.0 software (AniLab Software & Instruments Co., Ltd, China).
Fear conditioning
To test the effect of spatial training on the hippocampus-dependent associative memory. Rats were placed into a square chamber with a grid floor. On the first day, each rat was habituated to the chamber for 3 min, and then an auditory cue was delivered (70 dB, 30 s) followed by a foot shock (0.5 mA, 2 s). The same procedure was repeated two times with 2-min intervals. After 2 h, the rats were put into the same chamber for without any stimulus for 3 min, and freezing time was recorded for assessment of memory. On the next day, the rats were exposed to the same chamber without any stimulus for 3 min. The contextual conditioning was assessed by recording freezing behavior.
Morris water maze (MWM)
The standard MWM procedure with minor modifications was used for the spatial training. For spatial learning, the rats were trained in the water maze to find a hidden platform for 5 consecutive days, four trials per day (with a 40-min interval) from 8:00 AM to 14:00 AM. In each trial, the rat started from one of four quadrants facing the wall of the pool and ended when the animal climbed on the platform. If the rat did not locate the platform in 60 s, they were guided to the platform and to stay in the platform for 20 s uniformly. The swimming path and the time used to find the platform (latency) was recorded by a video camera. Spatial memory was tested after training. The platform was removed and the percentage of time spent in the target quadrant and the number of platform crossings were recorded.
Golgi staining
After the last BP measurement, rats were anesthetized with 6% chloral hydrate (0.6ml/kg, i.p.) and transcardially perfused with proximately 300 ml of normal saline containing 0.5% sodium nitrite, followed with 300 ml of 4% formaldehyde solution and then 500ml staining solution (5% chloral hydrate, 5% potassium dichromate and 4% formaldehyde) over 2 hours. Brains were removed from the skull and incubated in the staining solution for 3 days and in 1% silver nitrate solution for another 3 days in the dark. The silver nitrate solution was changed every day. Finally, the brains were sliced using a vibrate microtome (Leica, Wetzlar, Germany) at a thickness of 80μm.
Nissl staining
The slice was pasted on the slide and dried by airing for 24 h in room temperature. Use the toluidine blue (Wuhan Goodbio technology CO, LTD, China) to stain for1 min and wash by PBS for 10 min with three times. According to the color, use the 95% ethanol to decolorize for 3 min. Finally, use the absolute ethyl alcohol for dehydration for 5 min three times and the dimethylbenzene for transparency for 10 min twice. Image-Pro Plus software was used to analyze cell numbers. The areas covered in regions of the hippocampus were measured. Three to five coronal sections were analyzed per rat, and the average ratios were used to calculate group means.
Measurement of intracellular calcium concentration
Fura-3-acetoxymethyl ester (Fura-3-AM) is a membrane-permeable derivative of the ratiometric calcium indicator Fura-3 used in biochemistry to measure intracellular calcium concentrations [Ca2+]i by fluorescence. In this study, HEK293T cells were treated with 0.9%, 0.92%, 0.95% 0.98% NaCl solution. The cells were incubated for 30 minutes, grown in a humid atmosphere containing 5% CO2 at 37°C. Cells were then incubated with final concentration of 2μMFura-3-AM dissolved in dimethyl sulphoxide (DMSO) in the dark for 30 min, and washed cells three times with standard extra cellular fluid mentioned above in the dark, and then using confocal microscopy (Olympus, Tokyo, Japan) and analysis software to measure the intensity of fluorescence of randomly chosen cells which showed clear cell configuration.
Western blotting
The hippocampal tissues were rinsed twice in ice-cold PBS (pH 7.5) and lysed with buffer containing 10 mM Tris-Cl, pH 7.6, 50 mM NaF, 1 mM Na3VO4, 1 mM edetic acid, 1 mM benzamidine, 1 mM PMSF, and a mixture of aprotinin, leupeptin, and pepstatin A (10μg/ml each). After measurement of protein concentration in the extracts using BCA kit (Pierce, Rockford, IL), a final concentration of 10% β-mercaptoethanol and 0.05% bromophenol blue were added, and the samples were boiled for 10 min in a water bath for Western blotting. The proteins in the extracts were separated by 10% SDS-PAGE and transferred to nitrocellulose membrane. The membrane was then blocked in 5% non-fat milk for 1 hour at room temperature. The membranes were incubated with primary antibody at 4 °C for overnight. Then the blots were incubated with anti-rabbit or anti-Goat IgG conjugated to IRDye™ (800CW) (1:10000) for 1 h at room temperature. Immunoreactive bands were visualized using the Odyssey Infrared Imaging System (Licor biosciences, Lincoln, NE). To eliminate the variations due to protein quantity and quality, the data were adjusted to DM1A expression (IOD of objective protein versus IOD of DM1A protein).
ELISA quantification of Aβ
To detect the concentration of Aβin hippocampus, the rat hippocampus were homogenized in buffer (PBS with 5% BSA and 0.03%Tween-20, supplemented with protease inhibitor cocktail), and centrifuged at16,000g for 20 min. Aβ1-42 was quantified using the rat Aβ1-42 ELISA Kit (Elabscience, Wuhan, China) in accordance with the manufacturer's instructions. The Aβ concentrations were determined by comparison with the standard curve.
Statistical analysis
All experiments were repeated at least three times. Experimental values were obtained from three independent experiments with a similar pattern and expressed as means. Data were expressed as mean ± SEM and analyzed using SPSS 18.0 statistical software (SPSS Inc, Chicago, Illinois, USA). For analysis involving multiple groups, ANOVA procedure followed by Student-Newman-Keuls post hoc test with 95% confidence and Student's two-tailed t-test. Differences with p<0.05were considered significant.
Acknowledgments
This work was supported in parts by grants from National Natural Science Foundation of China (81571255 and 31528010), grant from Hubei Province Key Technology R&D Program (2015BCE094) and the Academic Frontier Youth Team Project to Xiao-Chuan Wang from Huazhong University of Science and Technology.
Abbreviations
- AD
Alzheimer's disease
- BP
blood pressure
- SBP
systolic blood pressure
- CBF
cerebral blood flow
Author contributions
X.-C.W. designed research; C. G., W. Z., F. H., M. Q., X. L., Y. M., and Q. W. performed research; R. L., J.Z. W., B. Z., H. -L. L. and X.-C.W. analyzed data; X.-C.W. wrote the paper.
CONFLICTS OF INTEREST
The authors of this manuscript have no conflicts of interest to declare.
REFERENCES
- 1.Shi Z, Nicholls SJ, Taylor AW, Magliano DJ, Appleton S, Zimmet P. Early life exposure to Chinese famine modifies the association between hypertension and cardiovascular disease. Journal of hypertension. 2017. [DOI] [PubMed]
- 2.Pastuszak Z, Stepien A, Kordowska J, Rolewska A, Galbarczyk D. Brain Strokes Related to Aortic Aneurysma - the Analysis of three Cases. Open medicine. 2017;12:58–61. doi: 10.1515/med-2017-0011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Tin A, Scharpf R, Estrella MM, Yu B, Grove ML, Chang PP, Matsushita K, Kottgen A, Arking DE, Boerwinkle E, Le TH Coresh J, Grams ME. The Loss of GSTM1 Associates with Kidney Failure and Heart Failure. Journal of the American Society of Nephrology. 2017. [DOI] [PMC free article] [PubMed]
- 4.Nistala R, Savin V. Diabetes, hypertension, and chronic kidney disease progression: role of DPP4. American journal of physiology Renal physiology. 2017;312:F661–F670. doi: 10.1152/ajprenal.00316.2016. [DOI] [PubMed] [Google Scholar]
- 5.Shah NS, Vidal JS, Masaki K, Petrovitch H, Ross GW, Tilley C, DeMattos RB, Tracy RP, White LR, Launer LJ. Midlife blood pressure, plasma beta-amyloid, and the risk for Alzheimer disease: the Honolulu Asia Aging Study. Hypertension. 2012;59:780–786. doi: 10.1161/HYPERTENSIONAHA.111.178962. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Ronnemaa E, Zethelius B, Lannfelt L, Kilander L. Vascular risk factors and dementia: 40-year follow-up of a population-based cohort. Dementia and geriatric cognitive disorders. 2011;31:460–466. doi: 10.1159/000330020. [DOI] [PubMed] [Google Scholar]
- 7.Kennelly SP, Lawlor BA, Kenny RA. Blood pressure and dementia - a comprehensive review. Therapeutic advances in neurological disorders. 2009;2:241–260. doi: 10.1177/1756285609103483. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Tzourio C, Dufouil C, Ducimetiere P, Alperovitch A. Cognitive decline in individuals with high blood pressure: a longitudinal study in the elderly. EVA Study Group. Epidemiology of Vascular Aging. Neurology. 1999;53:1948–1952. doi: 10.1212/wnl.53.9.1948. [DOI] [PubMed] [Google Scholar]
- 9.Guo Z, Fratiglioni L, Zhu L, Fastbom J, Winblad B, Viitanen M. Occurrence and progression of dementia in a community population aged 75 years and older: relationship of antihypertensive medication use. Archives of neurology. 1999;56:991–996. doi: 10.1001/archneur.56.8.991. [DOI] [PubMed] [Google Scholar]
- 10.Leritz EC, Salat DH, Williams VJ, Schnyer DM, Rudolph JL, Lipsitz L, Fischl B, McGlinchey RE, Milberg WP. Thickness of the human cerebral cortex is associated with metrics of cerebrovascular health in a normative sample of community dwelling older adults. NeuroImage. 2011;54:2659–2671. doi: 10.1016/j.neuroimage.2010.10.050. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Jennings JR, Mendelson DN, Muldoon MF, Ryan CM, Gianaros PJ, Raz N, Aizenstein H. Regional grey matter shrinks in hypertensive individuals despite successful lowering of blood pressure. Journal of human hypertension. 2012;26:295–305. doi: 10.1038/jhh.2011.31. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Nagai M, Hoshide S, Ishikawa J, Shimada K, Kario K. Ambulatory blood pressure as an independent determinant of brain atrophy and cognitive function in elderly hypertension. Journal of hypertension. 2008;26:1636–1641. doi: 10.1097/HJH.0b013e3283018333. [DOI] [PubMed] [Google Scholar]
- 13.Muller M, van der Graaf Y, Visseren FL, Mali WP, Geerlings MI, Group SS. Hypertension and longitudinal changes in cerebral blood flow: the SMART-MR study. Annals of neurology. 2012;71:825–833. doi: 10.1002/ana.23554. [DOI] [PubMed] [Google Scholar]
- 14.Matsushita K, Kuriyama Y, Nagatsuka K, Nakamura M, Sawada T, Omae T. Periventricular white matter lucency and cerebral blood flow autoregulation in hypertensive patients. Hypertension. 1994;23:565–568. doi: 10.1161/01.hyp.23.5.565. [DOI] [PubMed] [Google Scholar]
- 15.Iadecola C. Neurovascular regulation in the normal brain and in Alzheimer's disease. Nature reviews Neuroscience. 2004;5:347–360. doi: 10.1038/nrn1387. [DOI] [PubMed] [Google Scholar]
- 16.Girouard H, Iadecola C. Neurovascular coupling in the normal brain and in hypertension, stroke, and Alzheimer disease. Journal of applied physiology. 2006;100:328–335. doi: 10.1152/japplphysiol.00966.2005. [DOI] [PubMed] [Google Scholar]
- 17.Bragulat E, de la Sierra A, Antonio MT, Coca A. Endothelial dysfunction in salt-sensitive essential hypertension. Hypertension. 2001;37:444–448. doi: 10.1161/01.hyp.37.2.444. [DOI] [PubMed] [Google Scholar]
- 18.Lenda DM, Sauls BA, Boegehold MA. Reactive oxygen species may contribute to reduced endothelium-dependent dilation in rats fed high salt. American journal of physiology Heart and circulatory physiology. 2000;279:H7–H14. doi: 10.1152/ajpheart.2000.279.1.H7. [DOI] [PubMed] [Google Scholar]
- 19.Pedroso D, Nunes AR, Diogo LN, Oudot C, Monteiro EC, Brenner C, Vieira HL. Hippocampal neurogenesis response: What can we expect from two different models of hypertension? Brain research. 2016;1646:199–206. doi: 10.1016/j.brainres.2016.05.044. [DOI] [PubMed] [Google Scholar]
- 20.Takeshima T, Okayama M, Ae R, Harada M, Kajii E. Influence of family history on the willingness of outpatients to undergo genetic testing for salt-sensitive hypertension: a cross-sectional study. BMJ open. 2017;7:e016322. doi: 10.1136/bmjopen-2017-016322. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.La Verde M, Mule S, Zappala G, Privitera G, Maugeri G, Pecora F, Marranzano M. Higher adherence to the Mediterranean diet is inversely associated with having hypertension: is low salt intake a mediating factor? International journal of food sciences and nutrition. 2017. pp. 1–10. [DOI] [PubMed]
- 22.Saghazadeh A, Mahmoudi M, Dehghani Ashkezari A, Oliaie Rezaie N, Rezaei N. Systematic review and meta-analysis shows a specific micronutrient profile in people with Down Syndrome: Lower blood calcium, selenium and zinc, higher red blood cell copper and zinc, and higher salivary calcium and sodium. PloS one. 2017;12:e0175437. doi: 10.1371/journal.pone.0175437. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Colin-Ramirez E, Arcand J, Ezekowitz JA. Dietary Self-management in Heart Failure: High Tech or High Touch? Current treatment options in cardiovascular medicine. 2017;19:19. doi: 10.1007/s11936-017-0515-9. [DOI] [PubMed] [Google Scholar]
- 24.Moriguchi S, Kita S, Yabuki Y, Inagaki R, Izumi H, Sasaki Y, Tagashira H, Horie K, Takeda J, Iwamoto T, Fukunaga K. Reduced CaM Kinase II and CaM Kinase IV Activities Underlie Cognitive Deficits in NCKX2 Heterozygous Mice. Molecular neurobiology. 2017. [DOI] [PubMed]
- 25.Pugazhenthi S. Metabolic Syndrome and the Cellular Phase of Alzheimer's Disease. Progress in molecular biology and translational science. 2017;146:243–258. doi: 10.1016/bs.pmbts.2016.12.016. [DOI] [PubMed] [Google Scholar]
- 26.Dhikav V, Anand K. Potential predictors of hippocampal atrophy in Alzheimer's disease. Drugs & aging. 2011;28:1–11. doi: 10.2165/11586390-000000000-00000. [DOI] [PubMed] [Google Scholar]
- 27.Iqbal K, Grundke-Iqbal I, Zaidi T, Merz PA, Wen GY, Shaikh SS, Wisniewski HM, Alafuzoff I, Winblad B. Defective brain microtubule assembly in Alzheimer's disease. Lancet. 1986;2:421–426. doi: 10.1016/s0140-6736(86)92134-3. [DOI] [PubMed] [Google Scholar]
- 28.Wisniewski HM, Iqbal K, Bancher C, Miller D, Currie J. Cytoskeletal protein pathology and the formation of beta-amyloid fibers in Alzheimer's disease. Neurobiology of aging. 1989;10:409–412. doi: 10.1016/0197-4580(89)90079-1. discussion 412-404. [DOI] [PubMed] [Google Scholar]
- 29.Liu Z. Dietary sodium and the incidence of hypertension in the Chinese population: a review of nationwide surveys. American journal of hypertension. 2009;22:929–933. doi: 10.1038/ajh.2009.134. [DOI] [PubMed] [Google Scholar]
- 30.Ge Z, Guo X, Chen X, Tang J, Yan L, Ren J, Zhang J, Lu Z, Dong J, Xu J, Cai X, Liang H, Ma J. Association between 24 h urinary sodium and potassium excretion and the metabolic syndrome in Chinese adults: the Shandong and Ministry of Health Action on Salt and Hypertension (SMASH) study. The British journal of nutrition. 2015;113:996–1002. doi: 10.1017/S0007114514003833. [DOI] [PubMed] [Google Scholar]
- 31.Dalai N, Cui H, Yan M, Rile G, Li S, Su X. Risk factors for the development of essential hypertension in a Mongolian population of China: a case-control study. Genetics and molecular research. 2014;13:3283–3291. doi: 10.4238/2014.April.29.6. [DOI] [PubMed] [Google Scholar]
- 32.Chen J, Gu D, Huang J, Rao DC, Jaquish CE, Hixson JE, Chen CS, Chen J, Lu F, Hu D, Rice T, Kelly TN, Hamm LL, et al. Metabolic syndrome and salt sensitivity of blood pressure in non-diabetic people in China: a dietary intervention study. Lancet. 2009;373:829–835. doi: 10.1016/S0140-6736(09)60144-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Gomes PM, Sa RWM, Aguiar GL, Paes MHS, Alzamora AC, Lima WG, de Oliveira LB, Stocker SD, Antunes VR, Cardoso LM. Chronic high-sodium diet intake after weaning lead to neurogenic hypertension in adult Wistar rats. Scientific reports. 2017;7:5655. doi: 10.1038/s41598-017-05984-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Capone C, Faraco G, Peterson JR, Coleman C, Anrather J, Milner TA, Pickel VM, Davisson RL, Iadecola C. Central cardiovascular circuits contribute to the neurovascular dysfunction in angiotensin II hypertension. The Journal of neuroscience. 2012;32:4878–4886. doi: 10.1523/JNEUROSCI.6262-11.2012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Aronow WS. Hypertension and cognitive impairment. Annals of translational medicine. 2017;5:259. doi: 10.21037/atm.2017.03.99. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Walker KA, Power MC, Gottesman RF. Defining the Relationship Between Hypertension, Cognitive Decline, and Dementia: a Review. Curr Hypertens Rep. 2017;19:24. doi: 10.1007/s11906-017-0724-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Shaldon S, Salt Vienken J. the neglected silent killer. Seminars in dialysis. 2009;22:264–266. doi: 10.1111/j.1525-139X.2009.00606.x. [DOI] [PubMed] [Google Scholar]
- 38.Yu SP, Choi DW. Na(+)-Ca2+ exchange currents in cortical neurons: concomitant forward and reverse operation and effect of glutamate. The European journal of neuroscience. 1997;9:1273–1281. doi: 10.1111/j.1460-9568.1997.tb01482.x. [DOI] [PubMed] [Google Scholar]
- 39.Ricci G, Pirillo I, Tomassoni D, Sirignano A, Grappasonni I. Metabolic syndrome, hypertension, and nervous system injury: Epidemiological correlates. Clinical and experimental hypertension. 2017;39:8–16. doi: 10.1080/10641963.2016.1210629. [DOI] [PubMed] [Google Scholar]
- 40.Iadecola C, Yaffe K, Biller J, Bratzke LC, Faraci FM, Gorelick PB, Gulati M, Kamel H, Knopman DS, Launer LJ, Saczynski JS, Seshadri S, Zeki Al Hazzouri A, et al. Impact of Hypertension on Cognitive Function: A Scientific Statement From the American Heart Association. Hypertension. 2016;68:e67–e94. doi: 10.1161/HYP.0000000000000053. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Grundke-Iqbal I, Iqbal K, Tung YC, Quinlan M, Wisniewski HM, Binder LI. Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci U S A. 1986;83:4913–4917. doi: 10.1073/pnas.83.13.4913. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Iqbal K, Grundke-Iqbal I, Smith AJ, George L, Tung YC, Zaidi T. Identification and localization of a tau peptide to paired helical filaments of Alzheimer disease. Proc Natl Acad Sci U S A. 1989;86:5646–5650. doi: 10.1073/pnas.86.14.5646. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Lee VM, Balin BJ, Otvos L, Jr, Trojanowski JQ. A68: a major subunit of paired helical filaments and derivatized forms of normal Tau. Science. 1991;251:675–678. doi: 10.1126/science.1899488. [DOI] [PubMed] [Google Scholar]